The federal spending bill has an important provision for researchers, and Trump announced more MFN deals with pharma firms
Europe pulls Tavneos over trial integrity concerns, pricing concerns over AstraZeneca's hypertension drug, and more biotech news from The Readout
Heidi Overton, a doctor and White House adviser, is expected to be President Trump's pick to lead the FDA
WHO vaccine experts on Friday recommended a full-scale human trial of the only existing approved Ebola vaccine to see if it offers cross-protection against a deadly strain spreading in the DR Congo
The agency had initially refused to even review the application but reversed course after a public outcry
Dr. Anthony Fauci, who had heretofore never met a microphone from which he wished to social distance, refused to answer
Michael Kratsios, President Trump’s science adviser, proposed overhauling how the government funds research. Democrats said Mr. Trump’s actions had weakened science
The cost of Obamacare coverage is due to rise by a median of 14% next year, according to a new analysis, marking further turmoil for the law's marketplaces. Why it matters: It would mark the second straight year of double-digit premium increases in the individual market. Customers could be on the hook for thousands of more dollars in costs, worsening the health affordability crisis. The big picture: Insurers blame the hikes on rising costs of health care services and the expiration of enhanced Affordable Care Act subsidies, per the KFF analysis of 77 health plans' preliminary rate filings in 16 states and the District of Columbia. Some enrollees will get subsidies that would cushion the blow, but those who make more than 400% of the federal poverty level, or about $64,000 for a single person, won't qualify.Higher premiums also drive up the government's cost of subsidizing coverage for poorer individuals in the marketplace. Zoom in: The higher out-of-pocket costs are motivating some healthier enrollees, who are more price sensitive, to drop their coverage. That, in turn, makes the overall pool of enrollees sicker and more expensive to care for, causing an increase in overall premiums. Insurers estimate that the sicker risk pool drove premiums up by roughly four percentage points this year and expect a similar increase in 2027.While costs rise, the market is shrinking: Affordable Care Act enrollment already is down by about 3 million people year over year, to 19.2 million, according to federal data released last month. What they're saying: "When you see a decline in enrollment coupled with such a big spike in premiums, neither of those are exactly comforting signs," said Emma Wager, a senior policy analyst for KFF's Program on the ACA. Still, she added, "for now the market is holding strong" overall. The total of 19 million enrollees is still more than any year before 2024. Democrats are seizing on the enrollee drop-off as a campaign issue and blaming Republicans for
Today's D.C. Diagnosis newsletter covers maintaining diversity in drug trials and troubling trends in employer-based health insurance
States argue the rules will make it too hard for people to get the Medicaid coverage they're entitled too
The use of genome editing in early embryos has pulled back the curtain on the role of one of the key genes that orchestrates the first stages of human development,…